Background: Knowledge of risk factors for recurrence of colorectal adenomas may identify patients who could benefit from individual surveillance strategies. The aim of this study was to identify risk factors for recurrence of colorectal adenomas in a high-risk population.
Introduction
Colorectal adenomas are potential precursors of colorectal cancer 1 . The standard treatment is endoscopic polypectomy to prevent the progression to carcinoma 2 . However, following polypectomy the recurrence rate is approximately 50 per cent after 3 years 3 . Chemoprevention may therefore be relevant, and aspirin has proven effective in randomized clinical trials (RCTs) 4, 5 . Several studies 6 -9 have pointed to an additional benefit when aspirin is combined with calcium and vitamin D. Therefore, the authors designed a double-blind RCT to investigate the effect of oral aspirin, calcitriol (active vitamin D) and calcium treatment or placebo on the colorectal adenoma recurrence rate. The trial was stopped as the treatment had no effect on the primary outcome, colorectal adenoma recurrence after 3 years. Results of the primary analysis have been presented elsewhere 10 .
The additional analyses of the trial focus on risk factors for recurrence. Knowledge of risk factors may identify patients who will benefit from an alternative treatment approach and screening/surveillance programme 11 . Several risk factors have already been identified 3,12 -18 . However, this has not been investigated in a population with an increased risk of colorectal cancer: those with one adenoma larger than 1 cm in size, multiple adenomas or a family history of colorectal cancer. The aim of this study was to determine risk factors for recurrence of colorectal adenomas 3 years after polypectomy in a high-risk population.
Proximal adenoma recurrence following colonoscopy and polypectomy e101 recurrence of adenomas in the colon or rectum. The study was terminated prematurely because a planned interim analysis showed no effect of the treatment (data published elsewhere) 10 . The data presented here are secondary analyses from that study. The study was registered at clinicaltrials.gov (NCT00486512) The investigation included patients aged 40-75 years, of both sexes, who had a sporadic adenoma removed from the colon or rectum within the 3 months before the start of the study. These adenomas were classified as being either tubular, tubulovillous or villous. With the aim of including only patients with an increased risk of colorectal cancer, they had to meet one of three criteria: a single adenoma larger than 1 cm in diameter, multiple adenomas of any size, or an adenoma of any size and family history of colorectal cancer (first-degree relative). Following adenoma removal, the patients were followed up for 3 years, after which the study ended with a final colonoscopy. Patient characteristics and features of adenomas removed at the initial screening were investigated as potential risk factors for adenoma recurrence after 3 years. Pathological classification and dysplasia were graded according to validated measures 19, 20 .
Study outcomes were the proportion of patients with recurrence, number of recurrent adenomas, and location of recurrence (proximal versus distal). Proximal location included the transverse colon, ascending colon, hepatic flexure or caecum, whereas distal location comprised the splenic flexure, descending colon, sigmoid colon or rectum.
Statistical analysis
Univariable and multivariable analyses were performed. χ 2 test and Mann-Whitney U test were used to test the significance of binary and continuous outcomes respectively in univariable analyses of co-variables. Variables with a potential influence on risk of recurrence were incorporated into a generalized linear model with recurrence as dependent variable. These were age, sex, size of largest adenoma removed at screening, number of adenomas removed at screening, histology of the least favourable adenoma removed at screening (tubular, tubulovillous or villous (least favourable)), grade of dysplasia of the least favourable adenoma removed at screening (lowversus high-grade (least favourable)), location (distal versus proximal) of the first adenoma removed at screening, representing the most proximally located adenoma, and smoking status (never smoked, former smoker, current smoker). To account for an immeasurable effect of being in the treatment or placebo group, treatment group was included in the model. The reported interaction between non-steroidal anti-inflammatory drugs and smoking on adenoma recurrence 21 was accounted for by incorporating the term treatment × smoking status into the model. Wald statistics were used and estimates reported as odds ratios (ORs) with 95 per cent c.i. A model with the same variables was used for the outcomes number of recurrent adenomas (linear model), location of recurrent adenomas (binary model), histology at recurrence (binary model; tubular versus tubulovillous/villous) and size of recurrent adenomas (binary model; 10 mm or greater versus less than 10 mm). SPSS ® version 20 (IBM, Armonk, New York, USA) was used for statistical analysis. P ≤ 0⋅050 was considered statistically significant.
Results
At the time of the interim analysis, 427 patients had completed the study including a colonoscopy after 3 years, and 25⋅8 per cent of these had adenoma recurrence. Baseline characteristics of the patients and resected adenomas at the time of inclusion colonoscopy are shown in Tables 1 and 2 respectively.
Recurrence
Univariable analysis revealed that male sex, the number of adenomas removed at initial screening and age were risk factors for recurrence (Tables 1 and 2 ). The recurrence rate increased with age (P = 0⋅050) ( Table 3 ). For younger subjects (aged 50 years or less) the recurrence rate was 19 per cent (14 of 75), whereas for older people (aged over 70 years) it was 35 per cent (12 of 34). In multivariable analysis, age (P = 0⋅011) and number of adenomas removed (P < 0⋅001) at initial screening were identified as independent risk factors for recurrence ( Table 4) . There was a significant interaction between smoking and study treatment; the recurrence risk for current smokers versus patients who had never smoked was dependent on treatment group (active treatment or placebo) (P = 0⋅006). Subgroup analysis showed no effect of smoking status on recurrence for the placebo group. Because of this, P values for smoking status may be misleading and have Values in parentheses are 95 per cent c.i. Age and adenoma variables refer to the time of screening. A generalized linear model was used; the analysis was adjusted for interaction between treatment and smoking status. *Rectum, sigmoid colon, descending colon, splenic flexure; †ascending colon/caecum, hepatic flexure, transverse colon. P = 0⋅001 (Fisher's exact test).
been omitted. However, the interaction was included in the analysis and thereby accounted for.
Location of recurrent adenomas
Eighteen of 20 recurrent adenomas in patients aged 50 years or less at initial screening were located in the distal part of the colon, whereas more than 50 per cent were located in the proximal part in older patients (P = 0⋅001) ( Table 5 ). In the youngest age group, the majority of adenomas recurred in the rectum or sigmoid colon, whereas among older patients the recurrences were more widely spread (Fig. 1) . In multivariable analysis, age (OR 1⋅08, 95 per cent c.i. 1⋅02 to 1⋅14) and proximal location (OR 4⋅29, 1⋅35 to 13⋅69) at initial screening were independent risk factors for subsequent proximal location of recurrent adenomas after 3 years.
Number of recurrent adenomas
The number of adenomas at initial screening was independently associated with increased number of recurrent adenomas at 3 years (OR 1⋅16, 95 per cent c.i. 1⋅07 to 1⋅25). 
Additional factors
Histology (OR 0⋅97, 95 per cent c.i. 0⋅88 to 1⋅07), number of adenomas (OR 0⋅98, 0⋅96 to 1⋅01) and adenoma size (OR 1⋅03, 0⋅96 to 1⋅11) after 3 years showed no association with age at initial screening in multivariable analyses. The same was true for the remaining variables investigated.
Discussion
This study found that age and the number of adenomas removed at initial screening were risk factors for adenoma recurrence after 3 years. Age and proximal adenoma location at the time of screening were risk factors for proximal recurrence, and the number of adenomas at screening was associated with the number of recurrent adenomas. Earlier studies investigated risk factors for adenoma recurrence in the general population. Associations between age and risk of recurrence 14 and risk of proximal recurrence 17 have been shown previously, as has the association between the number of adenomas removed at initial screening and recurrence 3, 13, 14, 16 . The interaction between smoking and study medication found in the present study is supported by the previous finding of an interaction between smoking and aspirin treatment 21 . The literature supports a relationship between smoking and development of colorectal adenomas 22 as well as colorectal cancer 23 . However, no overall effect of smoking on adenoma recurrence was found in two large prospective studies 12, 18 . All primary outcome analyses in the present trial showed no effect of the treatment 10 . It is therefore assumed that the intervention may not have interfered significantly with the present results. An interaction between smoking status and treatment was found, but this was accounted for by incorporating the interaction into the final model. According to current guidelines, patients with a large number of adenomas are considered to be at high risk of recurrence; this affects the surveillance strategy and such patients have shorter intervals between colonoscopies 24, 25 . However, there is insufficient evidence to make recommendations on postpolypectomy surveillance based on age as a risk factor. In fact, some guidelines suggest stopping surveillance at a certain age (75-80 years) 24, 26 . In the light of the present results, together with the increased life expectancy of the general population, further consideration should be given to whether age alone should be a valid reason for discontinuation of surveillance.
